We are live on ! Find out more
CVS icon

CVS Health

1,815 hedge funds and large institutions have $58.2B invested in CVS Health in 2020 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 828 increasing their positions, 709 reducing their positions, and 144 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more call options, than puts

Call options by funds: $1.81B | Put options by funds: $1.16B

17% more repeat investments, than reductions

Existing positions increased: 828 | Existing positions reduced: 709

1.84% less ownership

Funds ownership: 78.06%76.22% (-1.8%)

3% less funds holding

Funds holding: 1,8631,815 (-48)

12% less capital invested

Capital invested by funds: $66.1B → $58.2B (-$7.97B)

21% less first-time investments, than exits

New positions opened: 114 | Existing positions closed: 144

45% less funds holding in top 10

Funds holding in top 10: 8446 (-38)

Holders
1,815
Holders Change
-48
Holders Change %
-2.58%
% of All Funds
36.62%
Holding in Top 10
46
Holding in Top 10 Change
-38
Holding in Top 10 Change %
-45.24%
% of All Funds
0.93%
New
114
Increased
828
Reduced
709
Closed
144
Calls
$1.81B
Puts
$1.16B
Net Calls
+$646M
Net Calls Change
-$38.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Brown Advisory
376
Brown Advisory
Maryland
$8.97M -$277K -4,452 -3%
KPCM
377
Kings Point Capital Management
New York
$8.92M +$933 +15 +0%
SAM
378
Scion Asset Management
California
$8.76M +$9.33M +150,000 New
AIM
379
Achmea Investment Management
Netherlands
$8.71M +$9.29M +149,235 New
Massachusetts Financial Services
380
Massachusetts Financial Services
Massachusetts
$8.71M -$2.19M -35,133 -19%
IIM
381
Intact Investment Management
Quebec, Canada
$8.7M +$311K +5,000 +3%
CIA
382
CCM Investment Advisers
South Carolina
$8.68M -$48K -772 -0.5%
BCM
383
Buckhead Capital Management
Georgia
$8.62M +$11.2K +180 +0.1%
GI
384
Gradient Investments
Minnesota
$8.47M +$116K +1,860 +1%
HI
385
HBK Investments
Texas
$8.36M +$3.91M +62,904 +78%
CCT
386
Country Club Trust
Missouri
$8.36M -$180K -2,890 -2%
HIMCH
387
Hartford Investment Management Co (HIMCO)
Connecticut
$8.32M -$310K -4,986 -3%
X
388
Xponance
Pennsylvania
$8.27M -$1.23M -19,838 -12%
NLGIA
389
Nippon Life Global Investors Americas
New York
$8.26M
CFG
390
Citizens Financial Group
Rhode Island
$8.23M +$6.51M +104,607 +287%
1IA
391
1834 Investment Advisors
Wisconsin
$8.12M +$289K +4,651 +3%
CCM
392
Cohen Capital Management
California
$8.07M +$1.85M +29,768 +27%
PMG
393
ProVise Management Group
Florida
$8.04M +$171K +2,755 +2%
SIC
394
Salem Investment Counselors
North Carolina
$7.82M -$112K -1,800 -1%
BCM
395
BTC Capital Management
Iowa
$7.8M +$459K +7,370 +6%
BFG
396
Beacon Financial Group
Texas
$7.78M -$351K -5,639 -4%
DA
397
DSC Advisors
Illinois
$7.74M +$36.5K +587 +0.4%
UB
398
UMB Bank
Missouri
$7.74M
BBL
399
Beck Bode LLC
Massachusetts
$7.65M +$720K +11,577 +10%
Cerity Partners
400
Cerity Partners
New York
$7.58M +$2.89M +46,368 +56%

CVS Hedge Fund Activity: Q3 2020 in Review

1,815 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2020, worth a combined $58.2B — down 12% from $66.1B a quarter earlier.

Sellers outnumbered buyers: 144 funds closed out of CVS and 114 opened new positions — a net loss of 30 holders — while 709 trimmed existing stakes and 828 added.

The largest buyer was Capital World Investors, adding an estimated $408M. The largest seller was Capital International Investors, cutting an estimated $708M.

  • 1,815 institutional investors held CVS Health (CVS) as of Q3 2020, down from 1,863 in Q2 2020.
  • Funds reported $58.2B of CVS Health stock for Q3 2020, down 12% quarter-over-quarter.
  • 114 funds opened new CVS Health positions in Q3 2020 and 144 closed out, a net change of -30 holders.
  • The largest CVS Health buyer in Q3 2020 was Capital World Investors, an estimated $408M added.
  • The largest CVS Health seller in Q3 2020 was Capital International Investors, an estimated $708M sold.

Based on aggregated 13F filings for Q3 2020.